Xiaomeng Liu

Chinese Academy Of Medical Sciences And Peking Union Medical College Beijing 100021
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

NDUFA12 is associated with poor prognosis and promotes malignant phenotypes and mitochondrial metabolic alterations in hepatocellular carcinoma.

NDUFA12 is associated with poor prognosis and promotes malignant phenotypes and mitochondrial metabolic alterations in hepatocellular carcinoma.

Journal: American journal of cancer research

Published: April 21, 2026

Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Journal: Frontiers in immunology

Published: April 16, 2026

Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia.

Journal: Frontiers in immunology

Published: January 19, 2026

Crosstalk Between Schwann Cells and CD4+ T Cells Promotes Perineural Invasion in Colorectal Cancer.

Crosstalk Between Schwann Cells and CD4+ T Cells Promotes Perineural Invasion in Colorectal Cancer.

Journal: Cancer research

Published: December 17, 2025

Ultra compact multi-channel particle sampler for personal exposure of particle chemical composition at hourly resolution.

Ultra compact multi-channel particle sampler for personal exposure of particle chemical composition at hourly resolution.

Journal: Environment international

Published: July 21, 2025

Laparoscopic vs. open liver resection for malignancies involving segment 7: short-term outcomes and learning curve analysis using propensity score matching.

Laparoscopic vs. open liver resection for malignancies involving segment 7: short-term outcomes and learning curve analysis using propensity score matching.

Journal: Surgical endoscopy

Published: July 11, 2025

Inhibition of nuclear receptor coactivator 5 overcomes acquired lenvatinib resistance driven by protein kinase B-mammalian target of rapamycin signaling in hepatocellular carcinoma.

Inhibition of nuclear receptor coactivator 5 overcomes acquired lenvatinib resistance driven by protein kinase B-mammalian target of rapamycin signaling in hepatocellular carcinoma.

Journal: Anti-cancer drugs

Published: May 14, 2025

Single-cell transcriptomic profiling reveals liver fibrosis in colorectal cancer liver metastasis.

Single-cell transcriptomic profiling reveals liver fibrosis in colorectal cancer liver metastasis.

Journal: Experimental & molecular medicine

Published: February 19, 2025

Characteristics of personal exposure to metals in PM2.5 and their implications for epidemiological studies: New insights from a panel study of the elderly in Beijing.

Characteristics of personal exposure to metals in PM2.5 and their implications for epidemiological studies: New insights from a panel study of the elderly in Beijing.

Journal: Environmental research

Published: January 10, 2025

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study.

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study.

Journal: Cancer immunology, immunotherapy : CII

Published: November 29, 2024

Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study.

Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study.

Journal: Frontiers in immunology

Published: November 19, 2024

Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer.

Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer.

Journal: Biomedicines

Published: November 11, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026